During the past decade, Universal Dermatology, PLLC conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Universal Dermatology, PLLC" are "Basal Cell Carcinoma" (1 trials), "Cutaneous T-Cell Lymphoma" (1 trials), "Malignant Skin Melanoma T0" (1 trials) and "Squamous Cell Carcinoma" (1 trials). Many other conditions were trialed in "Universal Dermatology, PLLC" in a lesser frequency.

Most popular intervention types in "Universal Dermatology, PLLC" are "Biological" (1 trials), "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Deep Ensemble for the Recognition of Malignancy (DERM)" (1 trials), "KW-0761" (1 trials) and "Vorinostat" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universal Dermatology, PLLC" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Universal Dermatology, PLLC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Universal Dermatology, PLLC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universal Dermatology, PLLC, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".